Evidence map›Paper›PMID 34097248›Full record

ReviewNatural products and bioprospecting2021

α-C(sp

Mei Wang, Wei Wang, Dashan Li, Wen-Jing Wang, Rui Zhan, Li-Dong Shao

Abstract readReview
In one paragraph

Review in Natural products and bioprospecting, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mei WangYunnan Key Laboratory of Southern Medicinal Utilization, School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, 650050, China.
Wei WangYunnan Key Laboratory of Southern Medicinal Utilization, School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, 650050, China.
Dashan LiYunnan Key Laboratory of Southern Medicinal Utilization, School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, 650050, China.
Wen-Jing WangYunnan Key Laboratory of Southern Medicinal Utilization, School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, 650050, China.
Rui ZhanSchool of Chemistry and Chemical Engineering, Yunnan Normal University, Kunming, 650050, China. sunnyzhanrui@126.com.
Li-Dong ShaoYunnan Key Laboratory of Southern Medicinal Utilization, School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, 650050, China. shaolidong@ynutcm.edu.cn.ORCID http://orcid.org/0000-0003-4799-6784

Funding

National Science of Foundation of China 81960631the Start-up Fund of Yunnan University of Chinese Medicine 2019YZG03Top Young Talent of Ten Thousand Talents Program of Yunnan Province R. Zhan and L.-D ShaoYunnan Fundamental Research Project 202001AS070038
6 · The paper itself

Abstract

α-C(sp

Indexed as

C-H functionalizationCyclic carbonyl compoundsα-C(sp3)-H arylation

Identifiers

PMID34097248
PMCPMC8275813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.